Pleomorphic Variant Mantle Cell Lymphoma Active Not Recruiting Phase 2 Trials for Sulfate ion (DB14546)

IndicationStatusPhase
DBCOND0119590 (Pleomorphic Variant Mantle Cell Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02427620Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell LymphomaTreatment